Top Suppliers:I want be here
Related CAS#:
22910-60-7 111047-30-4
20261-38-5 2281761-58-6
102811-39-2 444573-46-0
58682-65-8 6134-02-7
90176-52-6 91400-78-1
1158522-08-7 1506281-40-8
940364-43-2 134104-43-1
131615-57-1 6906-52-1
2034484-61-0 35509-63-8
930439-75-1 1018584-77-4

22910-60-7

22910-60-7 structure
22910-60-7 structure
  • Name: Ginkgolic acid C15:1
  • Chemical Name: 2-hydroxy-6-[(Z)-pentadec-8-enyl]benzoic acid
  • CAS Number: 22910-60-7
  • Molecular Formula: C22H34O3
  • Molecular Weight: 346.504
  • Catalog: Biochemical Chinese herbal medicine ingredients
  • Create Date: 2018-04-20 08:00:00
  • Modify Date: 2024-01-02 05:39:09
  • Ginkgolic Acid is a natural compound with suspected cytotoxic, allergenic, mutagenic and carcinogenic properties, and it can inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination.
Name 2-hydroxy-6-[(Z)-pentadec-8-enyl]benzoic acid
Synonyms MFCD03093717
15:1 anacardic acid
Ginkgolic acid
Ginkgolic acid 15:1
Romanicardic acid
(Z)-2-Hydroxy-6-(pentadec-8-en-1-yl)benzoic acid
Ginkgolic acid (15:1)
2-Hydroxy-6-(pentadec-8-en-1-yl)benzoic acid
(Z)-6-[8-pentadecenyl]salicylic acid
2-hydroxy-6-pentadec-8(Z)-enylbenzoic acid
6-[(8Z)-Pentadecenyl]-salicylic acid,Ginkgolic acid I
Ginkgoic acid
2-hydroxy-6-(8-pentadecenyl) salicylic acid
Anacardic acid monoene
6-(8-pentadecenyl)salicylic acid
2-Hydroxy-6-[(8Z)-pentadec-8-en-1-yl]benzoic acid
Ginkgolic acid I
Gingkolic Acid
2-Hydroxy-6-[(8Z)-8-pentadecen-1-yl]benzoic acid
6-(8Z-pentadecenyl)salicylic acid
Ginkgolic acid (C15:1)
6-<8(Z)-pentadecenyl>salicylic acid
Benzoic acid, 2-hydroxy-6-(8-pentadecenyl)-, (Z)-
Benzoic acid, 2-hydroxy-6-[(8Z)-8-pentadecen-1-yl]-
Ginkgolic Acid C15:1
(Z)-2-Hydroxy-6-(8-pentadecenyl)benzoic acid
Description Ginkgolic Acid is a natural compound with suspected cytotoxic, allergenic, mutagenic and carcinogenic properties, and it can inhibit protein SUMOylation both in vitro and in vivo without affecting in vivo ubiquitination.
Related Catalog
In Vitro Ginkgolic acid inhibits the in vitro SUMOylation of RanGAP1-C2 with the IC50 values of 3.0 μM. The level of SUMOylated p53 is markedly reduced by the ginkgolic acid treatment. Importantly, ginkgolic acid does not affect protein ubiquitination in cells. Ginkgolic acid inhibits the binding between E1 and GA-BODIPY in a dose-dependent manner[1]. Ginkgolic acid (31.2 μg/mL) inhibits HIV protease activity by 60%, compared with the negative control, and the effect is concentration-dependent. Ginkgolic acid treatment (50 and 100 μg/mL) effectively inhibits HIV infection in human PBMC cells. Ginkgolic acid at the concentrations up to 150 μg/mL does not cause any significant cytotoxicity in Jurkat cells[2]. GA only inhibits the growth of tumorogenic cell lines in a both dose- and time-dependent manner. Tumor cells are treated with GA for 72 h, 70.53±4.54% Hep-2 and 63.5±7.2% Tca8113 cells are retarded at GO/G1 phase, and the percentage of apoptosis is 40.4±1.58 and 38.4±1.7%, respectively. GA-treated activated caspase-3 downregulates the expression of anti-apoptotic Bcl-2 protein and upregulates the expression of pro-apoptotic Bax protein, eventually leading to a decrease in the Bcl-2/Bax ratio in tumor cellsin human PBMC cells. Ginkgolic acid at the concentrations up to 150 μg/mL does not cause any significant cytotoxicity in Jurkat cells[3].
Cell Assay Jurkat cells (106 cells/mL) are cultured in the RPMI medium with or without different concentrations of ginkgolic acid for 48 hours to test the cytotoxicity of ginkgolic acid. The cytotoxicity of ginkgolic acid is determined using a tetrazolium compound (MTS) and an electron coupling reagent (PMS). MTS is chemically reduced by cells into formazan, which is soluble in the tissue culture medium. The measurement of the absorbance of the formazan can be carried out using 96 well microplates at 492 nm. Since the production of formazan is proportional to the number of living cells, the intensity of the produced color is a good indication of the viability of the cells.
References

[1]. Fukuda I, et al. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol. 2009 Feb 27;16(2):133-40.

[2]. Lü JM, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298.

[3]. Zhou C, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402.

[4]. Qiu F, et al. Pharmacological inhibition of SUMO-1 with ginkgolic acid alleviates cardiac fibrosis induced by myocardial infarction in mice. Toxicol Appl Pharmacol. 2018 Apr 15;345:1-9.
Density 1.0±0.1 g/cm3
Boiling Point 492.1±40.0 °C at 760 mmHg
Melting Point 136-137ºC
Molecular Formula C22H34O3
Molecular Weight 346.504
Flash Point 265.5±23.8 °C
Exact Mass 346.250793
PSA 57.53000
LogP 9.44
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.527
Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335
Precautionary Statements P261-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi:Irritant;
Risk Phrases R36/37/38
Safety Phrases S26
RIDADR NONH for all modes of transport

Chemsrc provides CAS#:22910-60-7 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 22910-60-7 | Chemsrc address: https://www.chemsrc.com/en/baike/830478.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved